Guardant Health (GH) Reports Q3 Loss, Tops Revenue Estimates

Guardant Health (GH) came out with a quarterly loss of $0.45 per share versus the Zacks Consensus Estimate of a loss of$ 0.55. This compares to loss of $0.73 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 18.18%. A quarter ago, it was expected that this provider of oncology testing services would post a loss of$ 0.57 per share when it actually produced a loss of $0.48, delivering a surprise of 15.79%.Over the last four quarte ...